The Impact Study was published in the journal, The Lancet HIV with over 24,000 people taking part in the Impact Trial.
While PrEP has been in use for several years and proven to be effective in preventing HIV transmission, it is not the sole option for keeping HIV at bay.
PrEP should only be given to those at risk of contracting HIV (like sex workers, transgenders) and not to those who are not susceptible to HIV
There should be discipline while taking PrEP. Using substances, like alcohol or other drugs can impact its effectiveness.
PrEP is a valuable option in HIV prevention but should not be considered as a standalone option and needs to be promoted only with proper counselling and follow ups.
People need to ensure and be educated that PrEP is not the solution, but following safe sexual practices can keep you at bay from HIV.